# Sonoco Q3 2026: $732M Loss on $829M Goodwill Impairment

Sonoco Products Company (NYSE: SON), the Hartsville packaging maker, reported third-quarter 2026 net sales of \$2,041.6 million — down 4.2% year over year, though essentially flat excluding divestitures — and a GAAP net loss of \$732.1 million, or \$(7.36) per diluted share, against a \$122.9 million profit last year. The entire hole is a non-cash \$829 million goodwill impairment against the Consumer EMEA/APAC and Industrial APAC businesses, sitting inside \$856.4 million of restructuring and impairment charges that flipped operating profit of \$195.0 million into an operating loss of \$638.0 million. Underneath, the quarter was merely soft: gross margin slipped to 19.9% from 21.9% on \$1,636.3 million of cost of sales, SG\&A fell 15.4% to \$186.8 million, and interest expense dropped 23.8% to \$46.7 million on lower debt costs. A \$44.1 million tax provision landed on top of the \$(690.4) million pretax loss.

The adjusted view strips the write-down out: adjusted operating profit of \$268 million fell 13.1%, adjusted EBITDA of \$352 million fell 9.0%, and adjusted net income of \$167 million, or \$1.67 per share, fell 13.0% from \$1.92. Cash held up better than earnings — \$285 million of third-quarter operating cash flow, though year-to-date operating cash of \$218 million is net of roughly \$103 million of one-time taxes on the 2025 TFP and ThermoSafe sale gains. The balance sheet absorbed the hit: goodwill fell \$865.4 million to \$1,646.3 million and total equity dropped \$812.6 million to \$2,819.3 million, while long-term debt held flat at \$3,781.6 million and a September credit amendment added \$800 million of new term-loan capacity. Shareholders still got \$159 million of dividends over nine months (\$0.54 this quarter, up a penny). For the full year Sonoco guides \$7.20–7.40 billion of sales, adjusted EPS of \$5.30–5.50, adjusted EBITDA of \$1.20–1.25 billion, and operating cash flow reset to \$600–650 million.

## The Headline Numbers

| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net sales | \$2,041.6M (−4.2%) | \$2,131.1M |
| Gross margin | 19.9% | 21.9% |
| Restructuring / impairment | \$856.4M | \$48.4M |
| Operating (loss) profit | \$(638.0)M | \$195.0M |
| Net (loss) income, attributable | \$(732.1)M | \$122.9M |
| Diluted EPS | \$(7.36) | \$1.23 |
| Adjusted EBITDA | \$352M (−9.0%) | \$386M |
| Adjusted diluted EPS | \$1.67 (−13.0%) | \$1.92 |
| Operating cash flow (quarter) | \$285M | — |
| Quarterly dividend | \$0.54 | \$0.53 |
| Goodwill* | \$1,646.3M | \$2,511.6M |
| Long-term debt* | \$3,781.6M | \$3,789.0M |
| Total equity* | \$2,819.3M | \$3,631.8M |

\* Balance-sheet figures as of September 27, 2026 versus December 31, 2025.

Nine-month sales of \$5,603.5 million are down 2.6%, and the nine-month net loss of \$559.6 million compares with a \$670.8 million profit swollen by \$429.7 million of discontinued TFP income last year — the 2025 figure was the divestiture year, this one is the impairment year. The fourth quarter brings a test of the "more stable Consumer, continued strong Industrial" outlook management promised, plus a \$1.20–1.25 billion adjusted-EBITDA guide that needs roughly \$250–300 million in Q4 against nine-month adjusted EBITDA of \$952 million.

## Five years in the ledger: deals in, deals out, write-down

The ledger runs FY2021–FY2025 plus this quarter. Sales ran from \$5,590.4 million in the 2021 pension-settlement loss year to \$7,518.8 million with a full year of Eviosys, while attributable net income swung from a \$(85.5) million loss to a \$1,003.0 million 2025 peak fattened by the \$606.6 million TFP sale gain and the \$371.7 million ThermoSafe gain — EPS of \$10.07 that will stand as the high-water mark for a while. The balance sheet tells the deal story in sequence: the 2022 Ball Metalpack-era debt binge (long-term debt +\$1,520.7 million), the December 2024 Eviosys close (intangibles +\$1,733.0 million, total debt +\$3,957.0 million), the 2025 TFP exit, and now the \$829 million impairment clawing goodwill back. Every annual income statement and balance sheet, plus this quarter's exhibit statements, is modeled as examinable Beancount below.

<LedgerEmbed
  username="open_ledger"
  ledger="sonoco"
  page=""
  title="Sonoco Ledger FY2021–FY2026Q3"
/>

## Sources

- [Q3 2026 earnings release (Form 8-K exhibit, October 21, 2026)](https://www.sec.gov/Archives/edgar/data/91767/000009176726000047/ex99q32026earningsrelease.htm)
- [Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/91767/000009176726000008/son-20251231.htm)
